Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia (Q34123736)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

31 July 2017

Combined Analysis of CSF Tau, Aβ42, Aβ1-42% and Aβ1-40% in Alzheimer's Disease, Dementia with Lewy Bodies and Parkinson's Disease Dementia (English)

1 reference

Europe PubMed Central

31 July 2017

Alzheimer's disease

0 references

0 references

Parkinson's disease

1 reference

based on heuristic

inferred from title

dementia with Lewy bodies

1 reference

based on heuristic

inferred from title

Claudia Trenkwalder

4

object named as

Claudia Trenkwalder

0 references

object named as

Jens Wiltfang

7

0 references

Johannes Kornhuber

object named as

Johannes Kornhuber

6

0 references

Brit Mollenhauer

8

object named as

Brit Mollenhauer

1 reference

Europe PubMed Central

31 July 2017

3

object named as

Piotr Lewczuk

1 reference

Europe PubMed Central

31 July 2017

Hermann Esselmann

2

object named as

Hermann Esselmann

1 reference

Europe PubMed Central

31 July 2017

1

object named as

Mirko Bibl

1 reference

Europe PubMed Central

31 July 2017

author name string

Markus Otto

5

1 reference

Europe PubMed Central

31 July 2017

publication date

24 August 2010

1 reference

Europe PubMed Central

31 July 2017

International journal of Alzheimer's disease

1 reference

Europe PubMed Central

31 July 2017

2010

1 reference

Europe PubMed Central

31 July 2017

12701-12711

1 reference

Europe PubMed Central

31 July 2017

copyright license

Creative Commons Attribution 3.0 Unported

1 January 2010

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Neurochemical approaches in the laboratory diagnosis of Parkinson and Parkinson dementia syndromes: a review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Direct quantification of CSF alpha-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Neurochemical approaches of cerebrospinal fluid diagnostics in neurodegenerative diseases.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Neurochemical dementia diagnostics: State of the art and research perspectives

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Cerebrospinal fluid neurochemical phenotypes in vascular dementias: original data and mini-review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

CSF amyloid-beta-peptides in Alzheimer's disease, dementia with Lewy bodies and Parkinson's disease dementia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Cerebrospinal fluid protein biomarkers for Alzheimer's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Index for rating diagnostic tests

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Highly conserved and disease-specific patterns of carboxyterminally truncated Abeta peptides 1-37/38/39 in addition to 1-40/42 in Alzheimer's disease and in patients with chronic neuroinflammation.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Cerebrospinal-fluid tau protein and aspartate aminotransferase in Parkinson's disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2938459

5 July 2018

Validation of amyloid-beta peptides in CSF diagnosis of neurodegenerative dementias.

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Improved discrimination of AD patients using beta-amyloid(1-42) and tau levels in CSF.

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Cerebrospinal fluid markers in dementia with lewy bodies compared with Alzheimer disease.

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Tau protein, Abeta42 and S-100B protein in cerebrospinal fluid of patients with dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

CSF diagnosis of Alzheimer's disease and dementia with Lewy bodies.

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke.

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Consensus Report of the Working Group on: “Molecular and Biochemical Markers of Alzheimer’s Disease” 11The names of the Working Group Members and the names of the Working Group Advisory Committee Members are listed in the Appendix A(section VI)

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Amyloid beta peptide ratio 42/40 but not A beta 42 correlates with phospho-Tau in patients with low- and high-CSF A beta 40 load.

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Cerebrospinal fluid amyloidβ peptide patterns in Alzheimer's disease patients and nondemented controls depend on sample pretreatment: Indication of carrier-mediated epitope masking of amyloidβ peptides

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Effect of Sample Collection Tubes on Cerebrospinal Fluid Concentrations of Tau Proteins and Amyloid Peptides

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Beta-Amlyoid 1–42 and Tau-Protein in Cerebrospinal Fluid of Patients with Parkinson’s Disease Dementia

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Diagnostic and prognostic needs in neurodegenerative disorders: focus on proteomics

1 reference

https://api.crossref.org/works/10.4061%2F2010%2F761571

21 January 2018

Consensus report of the Working Group on: "Molecular and Biochemical Markers of Alzheimer's Disease". The Ronald and Nancy Reagan Research Institute of the Alzheimer's Association and the National Institute on Aging Working Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/20862375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Decreased CSF amyloid beta42 and normal tau levels in dementia with Lewy bodies

1 reference

https://pubmed.ncbi.nlm.nih.gov/20862375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cerebrospinal fluid Abeta40 and Abeta42: Natural course and clinical usefulness

1 reference

https://pubmed.ncbi.nlm.nih.gov/20862375

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.4061/2010/761571

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

1 reference

Europe PubMed Central

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34123736&oldid=1979788862"